By Celina Kareiva, Communications Associate, BID Initiative Posted in Monitoring & Evaluation , News , Policies & Practices Photo credit: Bill & Melinda Gates Foundation/Riccardo Gangale. Women and children wait for vaccinations at the Ngarenaro Health Center in Arusha, Tanzania. Last month, the World Health Organization (WHO) released new immunization data from 2017 that reveals globa

Acknowledgements WHO gratefully acknowledges the dedicated efforts of the numerous individuals and organizations involved with compiling this surveillance information, including Ministries of Health, sentinel hospitals, as well as the network of global, regional and national reference laboratories. WHO also gratefully acknowledges the financial support from Gavi, the Vaccine Alliance, that is prov

Improving the availability of reproductive health products in humanitarian settings JSI is working with the United Nations Population Fund to ensure the reproductive health (RH) rights of women and girls in humanitarian settings. We developed a global forecasting tool for emergency RH kits, which includes a dashboard to increase data visibility and helps advocate for increased investments in produ

By: Julia Roper, Associate-New Vaccine Introduction, and Tsepang Tsolele, Associate-Vaccines Rotavirus is the most common cause of diarrheal disease among children. In fact, nearly every child who is not vaccinated will experience rotavirus at some point by age five. For children in countries without access to vaccinations and treatment, rotavirus can be fatal. Rotavirus causes severe diarrhea, vo

By: Berrington Shayo, Vaccine Program Manager-Tanzania Aziz Sheshe is the Regional Vaccine and Immunization Officer for Tanzania’s Arusha region. He has been working with the government’s immunization program for the past 15 years. Aziz oversees immunization services at more than 300 health facilities across the region, with almost 260,000 children falling under his jurisdiction. His commitment to

By: Sarah Snidal, Senior Associate, New Vaccine Introduction, Global Vaccines Delivery Team There is a major global equity gap in cervical cancer prevention. Approximately 266,000 cervical cancer deaths and 528,000 new cases occur each year, making it the fourth most common cancer among women worldwide. Nearly 90 percent of the global deaths from cervical cancer occur in low- and middle-income reg

(Revised version including data from Colombia which had been erroneously excluded) Dear Colleagues,   We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhe

The Value of VAN: How Visibility and Analytics Networks Make Supply Chains Stronger The JSI IMPACT Team approach, which is customized for public health supply chains, helps professionals at different levels of the health system adopt a culture of continuous improvement by setting goals, selecting indicators for progress, and using data to track and correct performance. Read more   Scaling Up Innov

Are Unmanned Aerial Systems Cost Effective in Public Health Supply Chains?  p{ margin:10px 0; padding:0; } table{ border-collapse:collapse; } h1,h2,h3,h4,h5,h6{ display:block; margin:0; padding:0; } img,a img{ border:0; height:auto; outline:none; text-decoration:none; } body,#bodyTable,#bodyCell{ height:100%; margin:0; padding:0; width:100%; } .mcnPreviewText{ display:none !important; } #outlook a

Dear Colleagues,   We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia from the calendar year of 2016.    In this edition, we

Dear Colleagues,   We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia from the calendar year 2016. Please note that data inc

By: Divine Nzuobontane, Yauba Saidu and Joelle Sobngwi As we celebrate World Immunization Week, it is time to reflect on the powerful success of the polio vaccine and the importance of ensuring that all children have access to lifesaving vaccinations around the globe. Poliomyelitis (also known as polio) is a highly infectious viral disease, which mainly affects children under 5 years of age. The v

Dear Colleagues,   The World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks include strong laboratories that generate high quality data to monitor disease trends over time. The IB-VPD laboratory network supports the laboratory confirmation of disease caused byStreptococcus pneumoniae, (Spn)Haemophilus influen

Dear Colleagues,   We are happy to introduce an updated WHO Surveillance Bulletin. We’ve transformed the bulletin into an electronic format, and we are changing our bi-annual reporting to April and October to reflect when surveillance data are available. The bulletin still presents a summary of case-based Invasive Bacterial Vaccine-Preventable Disease and Rotavirus Surveillance Network data from a

By: Dr. Owens Wiwa & Abiola Ojumu On April 1, 2016, Mrs. Lovina Ogolo arrives at Foursees Primary Health Care Center in Rivers State, Nigeria with her six-week old grandson, David Ogolo, to receive his vaccinations. She shows up early at the clinic with other caregivers. Some were referred by friends or health workers, while others heard a radio advertisement that a new vaccine protecting babi

Original link Original author: Tina Damalas

To address these barriers to access, CHAI is pursuing four strategic objectives to support governments to increase access to immunization, ensuring that more children are protected from vaccine-preventable diseases. These objectives are to: 1. Increase the speed and efficiency with which new vaccines are introduced in developing countries; 2. Enhance the performance and efficiency of vaccine cold